| scholarly article | Q13442814 |
| P50 | author | Annette Gabriele Beck-Sickinger | Q6451282 |
| Stephan von Hörsten | Q37368871 | ||
| Noriyuki Kawamura | Q44830006 | ||
| P2093 | author name string | Takashi Yamamura | |
| Sachiko Miyake | |||
| Sammy Bedoui | |||
| Shinji Oki | |||
| Katsuichi Miyamoto | |||
| Youwei Lin | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| P304 | page(s) | 3451-3458 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo | |
| P478 | volume | 171 |
| Q34783246 | A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome |
| Q36403973 | A fundamental bimodal role for neuropeptide Y1 receptor in the immune system |
| Q75305446 | A vulnerability locus to multiple sclerosis maps to 7p15 in a region syntenic to an EAE locus in the rat |
| Q38034269 | At the crossroad of T cells, adipose tissue, and diabetes |
| Q45891909 | Attenuation of pain-related behaviour evoked by carrageenan injection through blockade of neuropeptide Y Y1 and Y2 receptors. |
| Q50079075 | Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration |
| Q36926476 | Combination therapies prevent the neuropathic, proinflammatory characteristics of bone marrow in streptozotocin-induced diabetic rats |
| Q36899708 | Differentially expressed genes in MHC-compatible rat strains that are susceptible or resistant to experimental autoimmune uveitis |
| Q43233507 | Editorial: regulation of the regulator: sympathetic nervous system control of regulatory T cells |
| Q37991266 | End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology. |
| Q35589934 | Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). |
| Q48411235 | Expression of heme oxygenase-1 in neural stem/progenitor cells as a potential mechanism to evade host immune response |
| Q37112554 | G protein-coupled receptors as therapeutic targets for multiple sclerosis |
| Q47875971 | Gene Expression Profiling of Multiple Sclerosis Pathology Identifies Early Patterns of Demyelination Surrounding Chronic Active Lesions |
| Q34472020 | Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein |
| Q46982061 | Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection |
| Q24298483 | Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells |
| Q35799802 | Involvement of calcitonin gene-related peptide and receptor component protein in experimental autoimmune encephalomyelitis |
| Q37770406 | Leptin as a metabolic link to multiple sclerosis |
| Q33935880 | Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells |
| Q43669793 | Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients |
| Q34333206 | Levels of neuropeptide Y in synovial fluid relate to pain in patients with knee osteoarthritis |
| Q35000999 | Micellar nanomedicine of human neuropeptide Y. |
| Q47950553 | Multiple Sclerosis: Implications of Obesity in Neuroinflammation |
| Q59831106 | Multiple loci comprising immune-related genes regulate experimental neuroinflammation |
| Q37408584 | Murine hypothalamic destruction with vascular cell apoptosis subsequent to combined administration of human papilloma virus vaccine and pertussis toxin |
| Q39456511 | Neuropeptide Y inhibits interleukin-1 beta-induced microglia motility |
| Q27312241 | Neuropeptide Y is produced by adipose tissue macrophages and regulates obesity-induced inflammation |
| Q34439028 | Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia. |
| Q36410642 | Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity |
| Q38702348 | Obesity and brain inflammation: a focus on multiple sclerosis. |
| Q39313146 | Protective role of neuropeptide Y Y₂ receptors in cell death and microglial response following methamphetamine injury |
| Q48111441 | Salivary Neuropeptides, Stress and Periodontitis. |
| Q27002574 | The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour |
| Q24795937 | Unaltered TNF-alpha production by macrophages and monocytes in diet-induced obesity in the rat. |
| Q34157261 | VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice |
Search more.